JAN 24, 2019 10:06 AM PST

Drug Slows Cancer's Circadian Clock

WRITTEN BY: Nouran Amin

According to a study done on human kidney cancer cells and acute myeloid leukemia cells in mice, a compound was examined to halt the cancerous growth by stunting the cell’s biological clock. The compound is named GO289 and works by targeting an enzyme that slows down the cell's circadian rhythm. Since disrupting the essential factors that make up the circadian rhythm can negatively impact health—the same applies for the circadian clock of cells which has concerned researchers that a compound like GO289 might affect healthy cells.

Learn more about circadian rhythms:

Essentially, the drug-protein interaction disrupts the functions of other proteins that are important for cell growth and survival. "In some cancers, the disease takes over the circadian clock mechanism and uses it for the evil purpose of helping itself grow," says Steve Kay, director of convergent biosciences at the USC Michelson Center and USC Provost Professor of Neurology, Biomedical Engineering and Biological Sciences. "With GO289, we can interfere with those processes and stop the cancer from growing."

The photograph shows an enlarged view of human bone cancer cells, which stopped growing when a drug molecule, GO289, jammed their circadian rhythm.

Credit: USC Michelson Center for Convergent Bioscience via ScienceDaily

However, the researchers wanted to see if GO289 hindered other cancers in anyway. They tested GO289 on human bone cancer cells and was examined to inhibit an enzyme named CK2--slowing down the tumors' circadian clock. They concluded that GO289 inhibited cancer cell metabolism and other circadian-related functions that normally would enable the cancer to metastasize.

Findings of the study were published in Science Advances and seeks to bring life to the study of circadian rhythms as a method of fight against cancer. "This could become an effective new weapon that kills cancer," says Kay.

Source: USC Dornsife

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 14, 2022
Drug Discovery & Development
COVID-19 Drug Combo More Effective than Single Drugs
APR 14, 2022
COVID-19 Drug Combo More Effective than Single Drugs
COVID-19 is more effectively treated by a combination of drugs than singular drugs alone. The corresponding study was pu ...
APR 20, 2022
Drug Discovery & Development
Vitamin E Stimulates Dendritic Cells, Boosts Immunotherapy Effectiveness
APR 20, 2022
Vitamin E Stimulates Dendritic Cells, Boosts Immunotherapy Effectiveness
Dendritic cells play an important role in the immune system. Specifically, they help gather up antigen-presenting cells ...
APR 28, 2022
Drug Discovery & Development
Keto Molecule Shows Promise for Treating Colorectal Cancer
APR 28, 2022
Keto Molecule Shows Promise for Treating Colorectal Cancer
A molecule produced when on low-carbohydrate ketogenic diets suppresses the growth of colorectal tumors in the lab. The ...
MAY 02, 2022
Drug Discovery & Development
Synthetic Coating Improves Survival of Oral Medications During Digestion
MAY 02, 2022
Synthetic Coating Improves Survival of Oral Medications During Digestion
We’re probably all familiar with the (sometimes unpleasant) experience of swallowing pills. Whether ibuprofen for ...
MAY 13, 2022
Drug Discovery & Development
Promising New Treatment for Cat Litter Parasite T. Gondii
MAY 13, 2022
Promising New Treatment for Cat Litter Parasite T. Gondii
Researchers have discovered a promising therapy for those suffering from toxoplasmosis, a disease caused by a parasite l ...
JUN 08, 2022
Coronavirus
How are you Preparing for the Next Covid Surge?
JUN 08, 2022
How are you Preparing for the Next Covid Surge?
After two years of uncertainty, we can definitely say that the coronavirus (Covid-19) has changed our everyday lives as ...
Loading Comments...